search
Company Information
USD
2.55
- (4.5%)
NASDAQ:MYNZ, MAINZ BIOMED NV
Industry: Diagnostics & Research
End of Day: 8 May 2025 GMT-4
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.

Address

Robert Koch Strasse 5
Sirius Gutenberg Park

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Dr. Heiner Dreismann,PhD
Director
Mr. Gregory J. Tibbitts
Director
Mr. William J. Caragol
CFO
Mr. Darin Leigh
Other Executive Officer
Mr. Guido Baechler
CEO/Director
Dr. Moritz Eidens
Chief Scientific Officer/Director
Dr. Alberto Libanori, PhD
Director
Mr. Hans Hekland
Director
Mr. Philipp Freese
COO
Mr. Nicole Holden
Director

Ownership

Institution Holdings

Fidelity Management & Research Company LLC
15,189 (0.075%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices